FDA
-
-
-
-
-
-
-
CytoSorbents Announces HotSwapâ„¢ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
-
-
-
-
-
-
-
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
-
-
-
-
-
-
-
CytoSorbents receives FDA appeal decision on DrugSorb-ATR device
-
-
-
-
-
-
-
Cytosorbents (CTSO) Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorbâ„¢-ATR
-
-
-
-
-
-
-
CytoSorbents Provides Regulatory Update for DrugSorb-ATR
-
-
-
-
-
-
-
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants
-
-
-
-
-
-
-
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
-
329,910 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

